华法林相关的脏病:揭示抗凝剂的隐藏危险
Fengbo Xu1, Guoqin Wang1, Lijun Sun1
1Department of Nephrology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Clinical and experimental medicine
|July 3, 2024
概括
华法林相关脏病 (WRN) 即使在具有机械假体门的患者中正常的国际正常化比率 (INR) 水平也可能发生. 这挑战了WRN的诊断标准,表明需要对特定患者群体进行重新评估.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 华法林相关病 (warfarin-related nephropathy,简称WRN) 是一种急性损伤,与过多的华法林抗凝剂有关.
- 带有机械假体的患者需要长期抗凝药,而华法林往往是唯一的选择.
- 这使得机械门患者在抗凝剂治疗中处于一个独特的类别.
研究的目的:
- 调查机械假体门患者中WRN的发生情况,特别是当国际正常化比率 (INR) 水平不升高时.
- 挑战WRN的确定的诊断标准,特别是对INR升高的要求.
- 在机械假肢患者的背景下,提出对WRN的修订理解.
主要方法:
- 关于两名在华法林治疗中使用机械假发的患者的案例研究,他们呈现出血和肌水平上升.
- 关于华法林相关脏病和IgA脏病的相关医学文献的审查.
- 分析脏活检和患者治疗结果.
主要成果:
- 两名接受华法林治疗的机械假发门患者患有IgA脏病的WRN,尽管INR水平不超过3.
- 两位患者继续接受华法林治疗,并接受皮质类固醇和环胺.
- 在治疗后的随访期间观察到功能得到改善.
结论:
- 升高的INR可能不是所有患者诊断WRN的强制性标准,特别是那些有机械假体门的患者.
- 即使在这个特定的患者群体中没有超治疗性INR水平,也应该考虑WRN.
- 需要进一步的研究来完善WRN诊断标准,用于长期治疗机械假体门的华法林患者.
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
672
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
672
01:24Disorders of Hemostasis
824
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
824
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
514
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
514
01:30Vitamins
653
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
653
01:13Therapeutic Index
4.2K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.2K